24-Gy low-voltage x-ray irradiation with ranibizumab therapy for neovascular AMD: 6-month safety and functional outcomes.

Canton, Virgilio Morales

24-Gy low-voltage x-ray irradiation with ranibizumab therapy for neovascular AMD: 6-month safety and functional outcomes. [electronic resource] - Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye - 20-4 p. digital

Publication Type: Clinical Trial, Phase I; Journal Article

1938-2375

10.3928/15428877-20111129-01 doi


Angiogenesis Inhibitors--adverse effects
Antibodies, Monoclonal, Humanized--adverse effects
Combined Modality Therapy
Fluorescein Angiography
Follow-Up Studies
Humans
Intravitreal Injections
Middle Aged
Radiotherapy Dosage
Ranibizumab
Tomography, Optical Coherence
Treatment Outcome
Visual Acuity--physiology
Wet Macular Degeneration--drug therapy